Vaccitech Oncology Limited
11655405
Healthy
- Loss before tax (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
31/12/2025
full
Next accounts due
30/09/2027
Confirmation statement
Last: 21/01/2026
Due 04/02/2027
Industry
Officers
director · Since 21/07/2020
HEAD OF CORPORATE FINANCE
BRITISH · UNITED KINGDOM · Age 45
Also on 5 other boards
Persons with Significant Control
Barinthus Biotherapeutics (Uk) Limited
3rd Floor, 1, Ashley Road, Altrincham, WA14 2DT
Reg: 9973585 · Companies House · Private Limited Company
Notified 01/11/2018
CompanyRankvs 810+ SIC 72110 peers67
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2025
Net Worth
£259k
Balance sheet strength
Cash
£342k
Cash in the bank
Profit Before Tax
-£96k
Bottom line earnings
Net Current Assets
£259k
Working capital
Current Assets
£347k
Current Liabilities
£88k
Debtors
£5k
Cost of Sales
£49k
Gross Profit
-£49k
Admin Expenses
£47k
Operating Profit
-£96k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 3.94 | -£933k |
| 2020 | 2.49 | — |
Derived from filed accounts. Not audited figures.